FDA approval for Fluticasone – Advair clinical trails

If you want to buy Fluticasone – Advair Online Click here to Compare Price of Fluticasone – Advair

FDA approval for Fluticasone – Advair

The U.S. FDA approved Fluticasone – Advair for sale in US as the latest treatment for the serious lung ailment that affects millions of people in the United States with chronic obstructive pulmonary disease-COPD linked with the chronic bronchitis. It is for the very first instance that the product having both anti-inflammatory drug called Fluticasone Propionate and the long-acting bronchodilator drug called Salmeterol that have been approved for such condition by the U.S. FDA.

COPD which incorporates chronic bronchitis and emphysema is the multifaceted lung ailment having certain components: inflammation, broncho-constriction and structural modification in the airways that obstruct airflow to and from the lungs. It is the unbearable and deteriorating condition that may lead to the loss of lung functions. Till the approval of Advair, only one medication was approved for treating the COPD linked with chronic bronchitis have been bronchodilators.

Most of the patients suffering from chronic bronchitis require multiple drugs to provide them managing with their conditions. Advair has a couple of drugs that function in different ways for enhancing lung functions which is the basic factor of COPD therapy. In the clinical trials Advair 250/50mcg exhibited remarkably noteworthy improvement in lung functions as compared to the singular usage of the most popular long-acting bronchodilator called Salmeterol.

The dose has been indicated for two times every day for maintaining treatment of airflow obstructions in the patients with COPD combined with chronic bronchitis. The approval of Advair for such condition is vital news for the patients and physicians. There is increasing recognition that COPD is the intricate ailment with multiple components. Advair is providing the advance approach as it has both anti-inflammatory and the bronchodilator that act combined for improving the lung functions.